| Patent | Date |
|---|
Modified Mullerian Inhibiting Substance (mis) Proteins And Uses Thereof For The Treatment Of Diseases
App 20220041677 - DONAHOE; Patricia K. ; et al. | 2022-02-10 |
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
Grant 11,135,269 - Donahoe , et al. October 5, 2 | 2021-10-05 |
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
Grant 11,084,860 - Donahoe , et al. August 10, 2 | 2021-08-10 |
Use Of Mullerian Inhibiting Substance (mis) Proteins For Contraception And Ovarian Reserve Preservation
App 20200376082 - DONAHOE; Patricia K. ; et al. | 2020-12-03 |
Mullerian Inhibiting Substance (mis) Proteins For Ovarian And Uterine Oncoprotection, And Ovarian Reserve And Uterine Preservati
App 20200071376 - DONAHOE; Patricia K. ; et al. | 2020-03-05 |
Uses Of Modified Mullerian Inhibiting Substance (mis) Proteins For The Treatment Of Neurodegenerative Diseases
App 20190351026 - DONAHOE; Patricia K. ; et al. | 2019-11-21 |
Viral vectors for expressing a modified mullerian inhibiting substance (MIS) protein
Grant 10,258,668 - Donahoe , et al. | 2019-04-16 |
Ovarian cancer stem cells and methods of isolation and uses thereof
Grant 9,791,449 - Donahoe , et al. October 17, 2 | 2017-10-17 |
Use Of Mullerian Inhibiting Substance (mis) Proteins For Contraception And Ovarian Reserve Preservation
App 20160310574 - DONAHOE; Patricia K. ; et al. | 2016-10-27 |
N-methyl Pyrazoloanthrone For Treatment Of Cancer
App 20160250190 - PEPIN; David ; et al. | 2016-09-01 |
Uses Of Modified Mullerian Inhibiting Substance (mis) Proteins For The Treatment Of Neurodegenerative Diseases
App 20160228514 - DONAHOE; Patricia K. ; et al. | 2016-08-11 |
Pyrazoloanthrone And Derivatives Thereof For Treatment Of Cancers Expressing Missrii
App 20160199352 - Teixeira; Jose ; et al. | 2016-07-14 |
Collecting ovarian cancer stem cells from ovarian cancer cells
Grant 9,289,492 - Donahoe , et al. March 22, 2 | 2016-03-22 |
Pyrazoloanthrone and derivatives thereof for the treatment of cancers expressing MISRII
Grant 9,260,759 - Teixeira , et al. February 16, 2 | 2016-02-16 |
Modified Mullerian Inhibiting Substance (mis) Proteins And Uses Thereof For The Treatment Of Diseases
App 20160039898 - DONAHOE; Patricia K. ; et al. | 2016-02-11 |
Ovarian Cancer Stem Cells And Methods Of Isolation And Uses Thereof
App 20140194366 - Donahoe; Patricia K. ; et al. | 2014-07-10 |
Pyrazoloanthrone And Derivatives Thereof For Treatment Of Cancer And Excess Androgen States
App 20120141605 - Teixeira; Jose ; et al. | 2012-06-07 |
Methods To Identify And Enrich For Populations Of Ovarian Cancer Stem Cells And Somatic Ovarian Stem Cells And Uses Thereof
App 20100273160 - Donahoe; Patricia K. ; et al. | 2010-10-28 |
Pyrazoloanthrone And Derivatives Thereof For The Treatment Of Cancer Expressing 'mullerian Inhibiting Substance' Type Ii Receptor (misrii) And Of Excess Androgen States
App 20100233689 - Teixeira; Jose ; et al. | 2010-09-16 |
Delivery of therapeutic biologicals from implantable tissue matrices
Grant 7,078,032 - MacLaughlin , et al. July 18, 2 | 2006-07-18 |
Use of mullerian inhibiting substance and interferon for treating tumors
App 20040151693 - Maheswaran, Shyamala ; et al. | 2004-08-05 |
Delivery of therapeutic biologicals from implantable tissue matrices
App 20040086497 - MacLaughlin, David T. ; et al. | 2004-05-06 |
Use of mullerian inhibiting substance for treating excess androgen states
App 20040062750 - Donahoe, Patricia K. ; et al. | 2004-04-01 |
Delivery of therapeutic biologicals from implantable tissue matrices
Grant 6,692,738 - MacLaughlin , et al. February 17, 2 | 2004-02-17 |
Use of Mullerian inhibiting substance for treating excess androgen states
Grant 6,673,352 - Donahoe , et al. January 6, 2 | 2004-01-06 |
Delivery of therapeutic biologicals from implantable tissue matrices
App 20020031500 - MacLaughlin, David T. ; et al. | 2002-03-14 |
Nucleic acids encoding a TGF-.beta. type 1 receptor
Grant 5,538,892 - Donahoe , et al. July 23, 1 | 1996-07-23 |
Purification of Mullerian inhibiting substance
Grant 5,310,880 - Donahoe , et al. May 10, 1 | 1994-05-10 |
Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
Grant 5,198,420 - Donahoe , et al. March 30, 1 | 1993-03-30 |
DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides
Grant 5,047,336 - Cate , et al. September 10, 1 | 1991-09-10 |
Purified Mullerian Inhibiting Substance and method of use
Grant 4,510,131 - Donahoe , et al. April 9, 1 | 1985-04-09 |
Purified Mullerian Inhibiting Substance and method of purification
Grant 4,404,188 - Donahoe , et al. September 13, 1 | 1983-09-13 |
| 